408 related articles for article (PubMed ID: 31395010)
21. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
[TBL] [Abstract][Full Text] [Related]
22. SYNGAP1: Mind the Gap.
Jeyabalan N; Clement JP
Front Cell Neurosci; 2016; 10():32. PubMed ID: 26912996
[TBL] [Abstract][Full Text] [Related]
23. Novel Mutation of SYNGAP1 Associated with Autosomal Dominant Mental Retardation 5 in a Chinese Patient.
Pei Y; Li W; Du L; Wei F
Fetal Pediatr Pathol; 2018 Dec; 37(6):400-403. PubMed ID: 30572772
[TBL] [Abstract][Full Text] [Related]
24. PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum.
Smith L; Singhal N; El Achkar CM; Truglio G; Rosen Sheidley B; Sullivan J; Poduri A
Epilepsia; 2018 Mar; 59(3):679-689. PubMed ID: 29377098
[TBL] [Abstract][Full Text] [Related]
25. Severe behavior problems in SYNGAP1-related disorder: A summary of 11 consecutive patients in a tertiary care specialty clinic.
Thomas BR; Ludwig NN; Falligant JM; Kurtz PF; Smith-Hicks C
Epilepsy Behav; 2024 Jan; 150():109584. PubMed ID: 38096660
[TBL] [Abstract][Full Text] [Related]
26. SYNGAP1-related developmental and epileptic encephalopathy: The impact on daily life.
Lo Barco T; De Gaetano L; Santangelo E; Bravi T; Proietti J; Cantalupo G; Brambilla I; Darra F
Epilepsy Behav; 2022 Feb; 127():108500. PubMed ID: 34954508
[TBL] [Abstract][Full Text] [Related]
27. Pharmacoresistant epileptic eyelid twitching in a child with a mutation in SYNGAP1.
Okazaki T; Saito Y; Hiraiwa R; Saitoh S; Kai M; Adachi K; Nishimura Y; Nanba E; Maegaki Y
Epileptic Disord; 2017 Sep; 19(3):339-344. PubMed ID: 28721930
[TBL] [Abstract][Full Text] [Related]
28. EEG endophenotypes in autism spectrum disorder.
Capal JK; Carosella C; Corbin E; Horn PS; Caine R; Manning-Courtney P
Epilepsy Behav; 2018 Nov; 88():341-348. PubMed ID: 30340903
[TBL] [Abstract][Full Text] [Related]
29. De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder.
Mirzaa GM; Chong JX; Piton A; Popp B; Foss K; Guo H; Harripaul R; Xia K; Scheck J; Aldinger KA; Sajan SA; Tang S; Bonneau D; Beck A; White J; Mahida S; Harris J; Smith-Hicks C; Hoyer J; Zweier C; Reis A; Thiel CT; Jamra RA; Zeid N; Yang A; Farach LS; Walsh L; Payne K; Rohena L; Velinov M; Ziegler A; Schaefer E; Gatinois V; Geneviève D; Simon MEH; Kohler J; Rotenberg J; Wheeler P; Larson A; Ernst ME; Akman CI; Westman R; Blanchet P; Schillaci LA; Vincent-Delorme C; Gripp KW; Mattioli F; Guyader GL; Gerard B; Mathieu-Dramard M; Morin G; Sasanfar R; Ayub M; Vasli N; Yang S; Person R; Monaghan KG; Nickerson DA; van Binsbergen E; Enns GM; Dries AM; Rowe LJ; Tsai ACH; Svihovec S; Friedman J; Agha Z; Qamar R; Rodan LH; Martinez-Agosto J; Ockeloen CW; Vincent M; Sunderland WJ; Bernstein JA; ; Eichler EE; Vincent JB; ; Bamshad MJ
Genet Med; 2020 Mar; 22(3):538-546. PubMed ID: 31723249
[TBL] [Abstract][Full Text] [Related]
30. Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy.
Mignot C; von Stülpnagel C; Nava C; Ville D; Sanlaville D; Lesca G; Rastetter A; Gachet B; Marie Y; Korenke GC; Borggraefe I; Hoffmann-Zacharska D; Szczepanik E; Rudzka-Dybała M; Yiş U; Çağlayan H; Isapof A; Marey I; Panagiotakaki E; Korff C; Rossier E; Riess A; Beck-Woedl S; Rauch A; Zweier C; Hoyer J; Reis A; Mironov M; Bobylova M; Mukhin K; Hernandez-Hernandez L; Maher B; Sisodiya S; Kuhn M; Glaeser D; Weckhuysen S; Myers CT; Mefford HC; Hörtnagel K; Biskup S; ; Lemke JR; Héron D; Kluger G; Depienne C
J Med Genet; 2016 Aug; 53(8):511-22. PubMed ID: 26989088
[TBL] [Abstract][Full Text] [Related]
31. 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment.
Writzl K; Knegt AC
Am J Med Genet A; 2013 Jul; 161A(7):1682-5. PubMed ID: 23687080
[TBL] [Abstract][Full Text] [Related]
32. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy.
Ahring PK; Liao VWY; Gardella E; Johannesen KM; Krey I; Selmer KK; Stadheim BF; Davis H; Peinhardt C; Koko M; Coorg RK; Syrbe S; Bertsche A; Santiago-Sim T; Diemer T; Fenger CD; Platzer K; Eichler EE; Lerche H; Lemke JR; Chebib M; Møller RS
Brain; 2022 May; 145(4):1299-1309. PubMed ID: 34633442
[TBL] [Abstract][Full Text] [Related]
33. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.
Fountain MD; Oleson DS; Rech ME; Segebrecht L; Hunter JV; McCarthy JM; Lupo PJ; Holtgrewe M; Moran R; Rosenfeld JA; Isidor B; Le Caignec C; Saenz MS; Pedersen RC; Morgan TM; Pfotenhauer JP; Xia F; Bi W; Kang SL; Patel A; Krantz ID; Raible SE; Smith W; Cristian I; Torti E; Juusola J; Millan F; Wentzensen IM; Person RE; Küry S; Bézieau S; Uguen K; Férec C; Munnich A; van Haelst M; Lichtenbelt KD; van Gassen K; Hagelstrom T; Chawla A; Perry DL; Taft RJ; Jones M; Masser-Frye D; Dyment D; Venkateswaran S; Li C; Escobar LF; Horn D; Spillmann RC; Peña L; Wierzba J; Strom TM; Parenti I; Kaiser FJ; Ehmke N; Schaaf CP
Genet Med; 2019 Aug; 21(8):1797-1807. PubMed ID: 30679821
[TBL] [Abstract][Full Text] [Related]
34. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy.
Parenti I; Lehalle D; Nava C; Torti E; Leitão E; Person R; Mizuguchi T; Matsumoto N; Kato M; Nakamura K; de Man SA; Cope H; Shashi V; ; Friedman J; Joset P; Steindl K; Rauch A; Muffels I; van Hasselt PM; Petit F; Smol T; Le Guyader G; Bilan F; Sorlin A; Vitobello A; Philippe C; van de Laar IMBH; van Slegtenhorst MA; Campeau PM; Au PYB; Nakashima M; Saitsu H; Yamamoto T; Nomura Y; Louie RJ; Lyons MJ; Dobson A; Plomp AS; Motazacker MM; Kaiser FJ; Timberlake AT; Fuchs SA; Depienne C; Mignot C
Hum Genet; 2021 Jul; 140(7):1109-1120. PubMed ID: 33944996
[TBL] [Abstract][Full Text] [Related]
35. An exploratory study of sleep quality and quantity in children with causal variants in SYNGAP1, an autism risk gene.
Paasch V; Doucoure A; Bifano M; Smith-Hicks CL
Sleep Med; 2023 Jul; 107():101-107. PubMed ID: 37146502
[TBL] [Abstract][Full Text] [Related]
36. Mouse models of
Araki Y; Gerber EE; Rajkovich KE; Hong I; Johnson RC; Lee HK; Kirkwood A; Huganir RL
Proc Natl Acad Sci U S A; 2023 Sep; 120(37):e2308891120. PubMed ID: 37669379
[TBL] [Abstract][Full Text] [Related]
37. Differential auditory brain response abnormalities in two intellectual disability conditions: SYNGAP1 mutations and Down syndrome.
Côté V; Knoth IS; Agbogba K; Vannasing P; Côté L; Major P; Michaud JL; Barlaam F; Lippé S
Clin Neurophysiol; 2021 Aug; 132(8):1802-1812. PubMed ID: 34130248
[TBL] [Abstract][Full Text] [Related]
38. Epilepsy and interictal epileptiform activity in patients with autism spectrum disorders.
Milovanovic M; Radivojevic V; Radosavljev-Kircanski J; Grujicic R; Toskovic O; Aleksić-Hil O; Pejovic-Milovancevic M
Epilepsy Behav; 2019 Mar; 92():45-52. PubMed ID: 30611007
[TBL] [Abstract][Full Text] [Related]
39. [Autosomal dominant mental retardation type 5 caused by
Wang XL; Tian YN; Chen C; Peng J
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):489-496. PubMed ID: 37272175
[TBL] [Abstract][Full Text] [Related]
40. EEG Abnormalities as a Neurophysiological Biomarker of Severity in Autism Spectrum Disorder: A Pilot Cohort Study.
Nicotera AG; Hagerman RJ; Catania MV; Buono S; Di Nuovo S; Liprino EM; Stracuzzi E; Giusto S; Di Vita G; Musumeci SA
J Autism Dev Disord; 2019 Jun; 49(6):2337-2347. PubMed ID: 30726535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
